Results 111 to 120 of about 6,881 (206)

How Are Deprescribing Clinical Practice Guidelines Disseminated and Implemented? A Cross-Sectional Study of International Organisational Stakeholders. [PDF]

Basic Clin Pharmacol Toxicol
Cheng CHJ, Gnjidic D, Mathieson S, Farrell BJ, McCarthy LM, Thompson W, Schneider CR.   +6 more
europepmc   +1 more source

Evaluation of a Pharmacist-Led Intervention Focused on the Deprescribing of Cardiovascular and Antidiabetic Medication in Older Patients With Polypharmacy: Patients' and Pharmacists' Experiences. [PDF]

Basic Clin Pharmacol Toxicol
Abou J, Elders PJM, van Marum R, Hugtenburg J.   +3 more
europepmc   +1 more source

Implementation of a hospital deprescribing behaviour change intervention, the CompreHensive geriAtRician-led MEdication Review (CHARMER) trial: a process evaluation protocol. [PDF]

BMJ Open
Martin-Kerry JM, Bhattacharya D, Taylor J, Kellar I, Atkins B, Jones CEL, Bywater-Florance EM, Keevil VL, Clark AB, Wright DJ, Alldred DP, Scott S.   +11 more
europepmc   +1 more source

Moving Deprescribing Upstream

Journal of General Internal Medicine, 2022
Michelle S. Keller, Sarah E. Vordenberg, Michael A. Steinman   +2 more
openaire   +4 more sources

Deprescribing decisions in palliative care: a qualitative meta-synthesis of multi-stakeholder experiences and influencing factors. [PDF]

BMC Palliat Care
Chen L, Wu Q, Zhang Y, Qu Y, Lei G, Wang Z.   +5 more
europepmc   +1 more source

Impact of Deprescribing Among Older Adults in Primary Care Settings: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. [PDF]

Aging Med (Milton)
Christopher CM, Kc B, Cheong MWL, Shrestha R, Shrestha S, Dujaili J, Blebil A.   +6 more
europepmc   +1 more source

Deprescribing of proton pump inhibitors in internal medicine in-patients: A retrospective observational study. [PDF]

Explor Res Clin Soc Pharm
Kotoula C, Schreck LD, Anandarathakrishnan A, Meyer-Massetti C, Aubert CE, Haschke M, Liakoni E.   +6 more
europepmc   +1 more source

Healthcare professionals' barriers and enablers concerning deprescribing in type 2 diabetes patients with polypharmacy: a focus group study. [PDF]

BMJ Open
Oktora MP, Yuniar CT, Hak E, Alfian SD, Abdulah R.   +4 more
europepmc   +1 more source

A qualitative study on the challenges in deprescribing for elderly patients with polypharmacy. [PDF]

Front Med (Lausanne)
Yang W, Li M, Wang Z, Liu Q, Jiang M, Tuo K, Zhang M, Xia B, Cao Y, Yang C.   +9 more
europepmc   +1 more source

Tailoring an Implementation Strategy for Deprescribing as Part of a Comprehensive Geriatric Assessment (dCGA) in Long-Term Care Facilities: A Roundtable Discussion. [PDF]

Basic Clin Pharmacol Toxicol
Belec D, Dalton K, Heinrich CH, Ortner Hadžiabdić M, Donovan MD.   +4 more
europepmc   +1 more source